NYSE · INFQ
Infleqtion Inc
$9.43-$0.20 (-2.08%)
Infleqtion Inc’s quoted price sits in the lower half of its reported 52-week range, 55.69% below the high.
Loading market information…
NASDAQ · PCSC · USD
Stock price, earnings
Quote as of Jul 20, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Perceptive Capital Solutions Corp Class A Ordinary Shares’s quoted price sits in the lower half of its reported 52-week range, 17.42% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Perceptive Capital Solutions Corp Class A Ordinary Shares’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Currently, Perceptive Capital Solutions Corp possesses no significant active operations. Its principal objective is to execute a strategic business combination—such as a merger, share swap, asset procurement, equity acquisition, or corporate restructuring—with one or more enterprises or entities engaged in the life sciences and medical technology sectors. These prospective partners are sought exclusively within North America or Europe. The company was established in 2024, with its corporate base located in New York, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$9.43-$0.20 (-2.08%)
Infleqtion Inc’s quoted price sits in the lower half of its reported 52-week range, 55.69% below the high.
$8.43+$0.10 (+1.2%)
Securitize Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.44% below the high.
$10.99+$0.01 (+0.09%)
American Exceptionalism Acquisition Corp. A’s quoted price sits in the lower half of its reported 52-week range, 8.34% below the high.
$9.33+$0.18 (+1.97%)
Contineum Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 47.55% below the high.
$11.08+$0.04 (+0.36%)
GP-Act III Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 7.67% below the high.
$3.11-$0.10 (-3.12%)
Xanadu Quantum Technologies Limited’s quoted price sits in the lower half of its reported 52-week range, 92.67% below the high.
$7.73-$0.69 (-8.19%)
Melar Acquisition Corp. I’s quoted price sits in the lower half of its reported 52-week range, 53.15% below the high.
$10.93+$0.07 (+0.64%)
IB Acquisition Corp. Common Stock’s quoted price sits in the upper half of its reported 52-week range, 6.1% below the high.
